(Q28066959)

main subject

hepatocellular carcinoma

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sang Hoon Ahn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Hye Won Lee

series ordinal

1

1 reference

Sang Hoon Ahn

series ordinal

2

1 reference

World Journal of Gastroenterology

language of work or name

1 reference

7 October 2016

5 references

23 March 2019

21 March 2019

3 April 2019

25 October 2022

8

1 reference

based on heuristic

inferred from page(s)

published in

6 references

23 March 2019

21 March 2019

3 April 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

25 October 2022

22

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

37

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

8314-8321

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

2 June 2020

copyright license

4 references

23 March 2019

21 March 2019

3 April 2019

on focus list of Wikimedia project

25 October 2022

ScienceSource

0 references

cites work

Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Chronic hepatitis B: update 2009

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Transient elastography: Kill two birds with one stone?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Diagnosis and personalized management of hepatitis B including significance of genotypes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Long-term outcome of chronic hepatitis B based on histological grade and stage.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Lamivudine for patients with chronic hepatitis B and advanced liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Epidemiological characteristics and risk factors of hepatocellular carcinoma

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

A 21-year experience with major hemorrhage after percutaneous liver biopsy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5055862

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

2 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

How to predict HCC development in patients with chronic B viral liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I37.8314

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/27729738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V22.I37.8314

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729738%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

27729738

2 references